Cvforlectures

CURRICULUM VITAE
TOMAS CUDRNAK
PERSONAL DETAILS
NAME Tomas CudrnakADDRESS 2 Mires Beck Close, Shipley, BD18 2NAE-MAIL ADDRESS [email protected] (work) +44 (0) 1612768044 FAX (work) +44 (0) 1612765642DATE OF BIRTH 07/08/1974HOME OFFICE STATUS EEA citizen - Slovak republicGMC NUMBER 6106666GMC REG. STATUS ful with specialist registration with a licence to practiceUK SPECIALIST REGISTER Ophthalmology from 15/07/2010 QUALIFICATIONS
Doctor of Medicine (M.D.) (9/1992 – 6/2000) - awarded 5/6/2000
Faculty of Medicine, Comenius University, Bratislava, Slovak Republic
Certificate of Specialisation in Ophthalmology Grade 1 - awarded 23/10/2003 The Institute of Postgraduate Education within the Health Care, Prague, Czech Republic Member of the Royal Col ege of Ophthalmologists (MRCOphth) - awarded 10/2007
The Royal Col ege of Ophthalmologists, London
Specialised Qualification in Ophthalmology - awarded 30/3/2009 The Ministry of Health, Prague, Czech Republic Specialisation Diploma in Ophthalmology - awarded 16/12/2009The Institute of Postgraduate Education within the Health Care, Prague, Czech Republic Fel ow of the Royal Col ege of Ophthalmologists (FRCOphth) - awarded 6/2010
The Royal Col ege of Ophthalmologists, London
Fel ow of the European Board of Ophthalmology (FEBO) - awarded 8/5/2010
The European Board of Ophthalmology, Paris
2nd place in EBO Diploma Examination 2010 (Highest Scores for Overal ) 2nd place in EBO Diploma Examination 2010 (Highest Scores for MCQs) MEMBERSHIP OF PROFESSIONAL ORGANISATIONS
The Royal Col ege of OphthalmologistsThe British Medical AssociationThe European Society of Retina SpecialistsThe European Vitreoretinal Society EMPLOYMENT HISTORY
Consultant Ophthalmic Surgeon and Medical Retina Specialist - since 22/10/12
Bradford Teaching Hospitals NHS Trust, Ophthalmology Department, Bradford, UK
Consultant Ophthalmic Surgeon and Medical Retina Specialist - 24/1/11 -
21/10/12 (21 months), Manchester Royal Eye Hospital, Manchester, UK
Associate Specialist in Ophthalmology - 1/11/2009 - 23/01/2011 (13 months)
Bradford Teaching Hospitals NHS Trust, Ophthalmology Department, Bradford, UK
Staff Grade Doctor in Ophthalmology – 08/02/2005 – 31/10/2009 (58 months)
Bradford Teaching Hospitals NHS Trust, Ophthalmology Department, Bradford, UK
Doctor in Training Ophthalmology (ST4-5 level) – 1/11/2003 – 30/11/2004
University Hospital in Ostrava, Ophthalmology Department, Ostrava, Czech Republic
Doctor in Training Ophthalmology (ST2-3 level) – 7/01/2002 – 31/10/2003
University Hospital in Ostrava, Ophthalmology Department, Ostrava, Czech Republic
Doctor in Training Ophthalmology (ST1-2 level) - 1/11/2000- 31/12/2001
University Children Hospital, Ophthalmology Department, Bratislava, Slovak Republic
TEACHING
- clinical and educational supervisor for ophthalmology trainees in North West deanery and - medical students and GP trainees - basic ophthalmologic examination techniques - optometrists - macular examination, anatomy and pathological findings, diabetic retinopathy - nursing/non-medical staff - OCT examination technique & interpretation in AMD patients Basic skil s course for ST1 ophthalmology trainees - 2008 OPTICUS - Part 2 MRCOphth revision course (2006-7) ‘Update on diabetic retinopathy’ - 2009 ‘JFT’s and differential diagnosis’ - 2009 'IVTA treatment for diffuse diabetic macular oedema' - 2008 'Laser treatment of diabetic macular oedema' - 2008 'Corticosteroids in Medical Retina' - 2011 Departmental Presentations/Lectures - 12x 2005-2010 Bradford 'Clinical Examination Tips & Interpretation of OCT' - 2011 MANAGEMENT
Active participation in the development of Macular service at the MREH Diabetic retinopathy lead at Airedale Associated Teaching Hospitals NHS Trust - 11/2009 - 11/2011 Active participation in the development of Macular service and Diabetic retinopathy service at Bradford Teaching Hospitals NHS Trust Coordinator at the RCO FRCOphth part 2 exam in Bradford - 11/2009 Organiser of the XII.Annual Meeting of the Czech Ophthalmologic Society (6/2004) MREH Experience with OZURDEX for RVO (6 months results) (2012) Longterm MREH Experience with Lucentis for wet AMD (2012) Macular Treatment Centre (MREH) patients flow audit (2011) Acute Response Clinic (BRI) audit (2010) Descemet striping endothelial keratoplasty (DSEK) - efficacy & complications (2009) Intravitreal triamcinolone in retinal diseases - safety & efficacy (2009) Departmental audit of laser treatment of diabetic macular oedema (2007) Audit of management of senile retinoschisis (2004) Timing of cataract extraction in glaucoma patients (2003) RESEARCH
COMRADE B - 6-months multinational double-masked randomised comparative study – BRVO associated macular oedema treatment with Ozurdex vs. Lucentis - since 2011 COMRADE C - 6-months multinational double-masked randomised comparative study – CRVO associated macular oedema treatment with Ozurdex vs. Lucentis - since 2011 LUMINOUS study - a multi-centre observational study - AMD treatment with Lucentis - RETAIN study - a multi-centre double-masked randomised comparative study - DME treatment with Lucentis vs. laser - since 2011 GMAN study - an open labeled single-site comparative study - AMD treatment with continuous vs. as required Avastin - since 2011 INTREPID study - a multinational randomised comparative study - IRay (radiotherapy) for IVAN study - a multi-centre double-masked randomised comparative study - AMD treatment with Lucentis vs. Avastin - 2008 - 2011 Effect of Choline Fenofibrate on DME (Solvay) - a multi-centre placebo-control ed

Source: http://www.femtofako.sk/pdf/CVforLectures.pdf

Star_results_french.doc

Les premiers résultats de l’étude STAR (Study of Tamoxifen and Raloxifene) sont disponibles : le Raloxifène, traitement de l’ostéoporose, est aussi efficace que le Tamoxifène dans la prévention du cancer du sein infiltrant. Les premiers résultats de l’étude STAR (Study of Tamoxifen and Raloxifene) montrent que le raloxifène, habituellement utilisé dans la prévention et le tr

geroservices.com

Long-Term Care of Patients With Frontotemporal Dementia Jennifer J. Merrilees, RN, MS, and Bruce L. Miller, MD Frontotemporal dementia (FTD) results from the progres-onstrate alterations in dress and hygiene. Hyperorality andsive dysfunction of the frontal and/or temporal lobes of theritualistic behaviors around eating can occur. Socially inap-brain. It is a presenile dementia with a me

Copyright © 2018 Medical Abstracts